Home » Newsletters » BioWorld Science

BioWorld Science

June 3, 2021

View Archived Issues

Novel synthetic biotic to promote mucosal healing for treatment of IBD

CIDEC gene silencing ameliorates experimental diabetic cardiomyopathy

Researchers develop new model of extracorporeal membrane oxygenation thrombosis

ADO-09 shown to be superior to insulin aspart in type 1 diabetes patients

ATTR removal observed in vitro and in vivo with NI-006

Encouraging development updates for SupraAntigen-derived liposomal AD vaccine candidates

Centivax enters strategic partnership with NMRC for phase I development of Centi-B9

First patient enrolled in phase Ib study of LB-100 for treatment of small cell lung cancer

Wave Life Sciences presents promising preclinical data for its ADAR editing program

Lophora ApS patents 5-HT2A receptor agonists

Nurix Therapeutics presents new PROTACs

Crinetics Pharmaceuticals synthesizes new melanocortin MC2 receptor antagonists

Merck & Co. identifies nicotinic alpha7 receptor PAMs

Suzhou Zelgen Biosciences synthesizes new GTPase KRAS mutant inhibitors

Phase II results presented from study comparing AZD-9567 versus prednisolone in active RA

Preclinical and early clinical characterization of VIB-7734

Epeleuton shows efficacy in preclinical models of atherosclerosis

New biomarkers identified for diagnosis of Cushing's syndrome

U.K. study identifies another danger of COVID-19: increased antibiotic resistance

Replimune provides updated clinical data for RP-1 and RP-2 programs

Mindset selects its lead next-generation psychedelic candidate, MSP-1014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...